NEW AWARD - PROGNOSTIC AND THERAPEUTIC SIGNIFICANCE OF COP9 SIGNALOSOME SUBUNIT CSN5 IN PROSTATE CANCER, EFFECTIVE 4/1/2020, SIGNED 2/21/2020, DISTRIBUTED 2/24/2020, FAADC 2/24/2020
$1,320,286FY2020Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research